Strategic review24 Apr 2026 02:01
Afentra's strategic review has no fixed deadline and could last for several months. This is because the company has been granted a key exemption from the UK Takeover Code's usual 28-day 'put up or shut up' (PUSU) rule.
When a company announces a possible offer, it normally triggers a 28-day PUSU deadline (Rule 2.6(a)), forcing the bidder to either make a firm offer or walk away. However, when a company initiates a formal sale process as part of a strategic review, it can seek a 'dispensation' from the Takeover Panel to pause this clock. Afentra has been granted exactly this, meaning it is not bound by the 28-day rule for as long as it is participating in the formal sale process.
Recent Status: "Ongoing"
Recent updates confirm that the review is still active:
· On April 23, 2026, the board stated the review remains ongoing.
· The review was launched on March 19, 2026, when the board, with Jefferies, began exploring a potential sale among other options.
Ultimately, the board has the flexibility to extend the review to secure the best outcome, and they can also decide at any point to end it and keep the company independent.
Summary
Afentra's strategic review is not subject to any hard legal time limit. It will continue until the board either secures a deal, decides to remain independent, or chooses to end the process, which could take several more months.
Jefferies was appointed by Afentra's board to conduct the strategic review. Their role is to contact potential buyers (financial or strategic investors), evaluate bids, and manage a potential sale process.
As Afentra's corporate broker and financial adviser, Jefferies is legally required to file a Form 8.5 disclosure daily when they're active in the market. These filings, like the one on April 22, 2026, confirm they've not taken a direct stake in the company (as shown by zero holdings in securities and derivatives). Their duty is simply to manage the sale process, not to act as a bidder themselves.
Not long now